Post-pandemic Era-Global Leukocyte Surface Antigen CD47 Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type

Report ID: 246969 | Published Date: Jan 2025 | No. of Page: 82 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Leukocyte Surface Antigen CD47 Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 B-6H12 -Product Introduction and Major Manufacturers
      1.1.2 ALX-148 -Product Introduction and Major Manufacturers
      1.1.3 CC-90002 -Product Introduction and Major Manufacturers
      1.1.4 PSTx-23 -Product Introduction and Major Manufacturers
      1.1.5 Others -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
    2.1 Regional Market Share in Terms of Production (2019-2026)
    2.2 Regional Market Share in Terms of Revenue (2019-2026)
    2.3 Regional Market Share in Terms of Consumption (2019-2026)
3 Global Leukocyte Surface Antigen CD47 Market Assessment by Type
    3.1 Global Leukocyte Surface Antigen CD47 Production by Type (2015-2026)
    3.2 Global Leukocyte Surface Antigen CD47 Revenue by Type (2015-2026)
    3.3 North America Leukocyte Surface Antigen CD47 Production and Revenue by Type (2015-2026)
    3.4 Asia Leukocyte Surface Antigen CD47 Production and Revenue by Type (2015-2026)
    3.5 Europe Leukocyte Surface Antigen CD47 Production and Revenue by Type (2015-2026)
    3.6 Middle East & Africa Leukocyte Surface Antigen CD47 Production and Revenue by Type (2015-2026)
    3.7 South America Leukocyte Surface Antigen CD47 Production and Revenue by Type (2015-2026)

4 Global Leukocyte Surface Antigen CD47 Market Assessment by Application
    4.1 Historical & Forecast Global Leukocyte Surface Antigen CD47 Consumption, Different Application Field (2015-2026)
    4.2 Historical & Forecast North America Leukocyte Surface Antigen CD47 Consumption, Different Application Field (2015-2026)
    4.3 Historical & Forecast Asia Leukocyte Surface Antigen CD47 Consumption, Different Application Field (2015-2026)
    4.4 Historical & Forecast Europe Leukocyte Surface Antigen CD47 Consumption, Different Application Field (2015-2026)
    4.5 Historical & Forecast Middle East & Africa Leukocyte Surface Antigen CD47 Consumption, Different Application Field (2015-2026)
    4.6 Historical & Forecast South America Leukocyte Surface Antigen CD47 Consumption, Different Application Field (2015-2026)

5 North America
    5.1 US Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    5.2 Canada Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    5.3 Mexico Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6 Asia
    6.1 China Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.2 Japan Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.3 India Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.4 Korea Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.5 Southeat Asia Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7 Europe
    7.1 Germany Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.2 UK Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.3 France Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.4 Russia Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.5 Italy Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8 Middle East and Africa
    8.1 Saudi Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.2 UAE Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.3 Egypt Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.4 Nigeria Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.5 South Africa Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9 South America
    9.1 Brazil Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    9.2 Argentina Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    9.3 Colombia Leukocyte Surface Antigen CD47 Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
10 Global Leukocyte Surface Antigen CD47 Average Price Trend
    10.1 Market Price for Each Type of Leukocyte Surface Antigen CD47 in North America (2015-2026)
    10.2 Market Price for Each Type of Leukocyte Surface Antigen CD47 in Asia (2015-2026)
    10.3 Market Price for Each Type of Leukocyte Surface Antigen CD47 in Europe (2015-2026)
    10.4 Market Price for Each Type of Leukocyte Surface Antigen CD47 in Middle East & Africa (2015-2026)
    10.5 Market Price for Each Type of Leukocyte Surface Antigen CD47 in South America (2015-2026)

11 Value Chain (Impact of COVID-19)
    11.1 Leukocyte Surface Antigen CD47 Value Chain Analysis
      11.1.1 Upstream
      11.1.2 Downstream
    11.2 COVID-19 Impact on Leukocyte Surface Antigen CD47 Industry
      11.2.1 Industrial Policy Issued Under the Epidemic Situation
    11.3 Cost-Under the Epidemic Situation
      11.3.1 Cost of Raw Material
    11.4 Channel Analysis
      11.4.1 Distribution Channel-Under the Epidemic Situation
      11.4.2 Distributors

12 Leukocyte Surface Antigen CD47 Competitive Analysis
     12.1 Aurigene Discovery Technologies
        12.1.1 Aurigene Discovery Technologies Company Profiles
        12.1.2 Aurigene Discovery Technologies Product Introduction
        12.1.3 Aurigene Discovery Technologies Leukocyte Surface Antigen CD47 Production, Revenue (2015-2020)
        12.1.4 SWOT Analysis
     12.2 Celgene
        12.2.1 Celgene Company Profiles
        12.2.2 Celgene Product Introduction
        12.2.3 Celgene Leukocyte Surface Antigen CD47 Production, Revenue (2015-2020)
        12.2.4 SWOT Analysis
     12.3 Forty Seven
        12.3.1 Forty Seven Company Profiles
        12.3.2 Forty Seven Product Introduction
        12.3.3 Forty Seven Leukocyte Surface Antigen CD47 Production, Revenue (2015-2020)
        12.3.4 SWOT Analysis
     12.4 Surface Oncology
        12.4.1 Surface Oncology Company Profiles
        12.4.2 Surface Oncology Product Introduction
        12.4.3 Surface Oncology Leukocyte Surface Antigen CD47 Production, Revenue (2015-2020)
        12.4.4 SWOT Analysis
        12.5.1 Trillium Therapeutics Company Profiles
        12.5.2 Trillium Therapeutics Product Introduction
        12.5.3 Trillium Therapeutics Leukocyte Surface Antigen CD47 Production, Revenue (2015-2020)
        12.5.4 SWOT Analysis
13 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Leukocyte Surface Antigen CD47 Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table Regional Market Share in Terms of Production (2019-2026)
    Figure Regional Market Share in Terms of Production (2019 - 2020)
    Table Regional Market Share in Terms of Revenue (2019-2026)
    Figure Regional Market Share in Terms of Revenue (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Table Global Leukocyte Surface Antigen CD47 Production (K Unit) by Type (2015-2026)
    Figure Global Leukocyte Surface Antigen CD47 Production (K Unit) and Growth Rate (2015-2026)
    Figure Global Leukocyte Surface Antigen CD47 Production Market Share (%) by Type (2019 -2020)
    Table Global Leukocyte Surface Antigen CD47 Revenue (Million USD) by Type (2015-2026)
    Figure Global Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Global Leukocyte Surface Antigen CD47 Revenue Market Share (%) by Type (2019-2020)
    Figure North America Leukocyte Surface Antigen CD47 Production (K Unit) by Type (2015-2026)
    Figure North America Leukocyte Surface Antigen CD47 Production (K Unit) and Growth Rate (2015-2026)
    Figure North America Leukocyte Surface Antigen CD47 Revenue (Million USD) by Type (2015-2026)
    Figure North America Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Asia Leukocyte Surface Antigen CD47 Production (K Unit) by Type (2015-2026)
    Figure Asia Leukocyte Surface Antigen CD47 Production (K Unit) and Growth Rate (2015-2026)
    Figure Asia Leukocyte Surface Antigen CD47 Revenue (Million USD) by Type (2015-2026)
    Figure Asia Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Europe Leukocyte Surface Antigen CD47 Production (K Unit) by Type (2015-2026)
    Figure Europe Leukocyte Surface Antigen CD47 Production (K Unit) and Growth Rate (2015-2026)
    Figure Europe Leukocyte Surface Antigen CD47 Revenue (Million USD) by Type (2015-2026)
    Figure Europe Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Middle East & Africa Leukocyte Surface Antigen CD47 Production (K Unit) by Type (2015-2026)
    Figure Middle East & Africa Leukocyte Surface Antigen CD47 Production (K Unit) and Growth Rate (2015-2026)
    Figure Middle East & Africa Leukocyte Surface Antigen CD47 Revenue (Million USD) by Type (2015-2026)
    Figure Middle East & Africa Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2015-2026)
    Figure South America Leukocyte Surface Antigen CD47 Production (K Unit) by Type (2015-2026)
    Figure South America Leukocyte Surface Antigen CD47 Production (K Unit) and Growth Rate (2015-2026)
    Figure South America Leukocyte Surface Antigen CD47 Revenue (Million USD) by Type (2015-2026)
    Figure South America Leukocyte Surface Antigen CD47 Revenue (Million USD) and Growth Rate (2015-2026)
    Table Historical & Forecast Leukocyte Surface Antigen CD47 Different Application Field Consumption (K Unit)
    Figure Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Different Application Field Consumption Market Share (%) (2019-2020)
    Table Historical & Forecast Leukocyte Surface Antigen CD47 Different Application Field Consumption (K Unit)
    Figure North America Leukocyte Surface Antigen CD47 Consumption (K Unit) and Growth Rate (2015-2026)
    Figure North America Leukocyte Surface Antigen CD47 Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Leukocyte Surface Antigen CD47 Different Application Field Consumption (K Unit)
    Figure Asia Leukocyte Surface Antigen CD47 Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Asia Leukocyte Surface Antigen CD47 Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Leukocyte Surface Antigen CD47 Different Application Field Consumption (K Unit)
    Figure Europe Leukocyte Surface Antigen CD47 Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Europe Leukocyte Surface Antigen CD47 Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Leukocyte Surface Antigen CD47 Different Application Field Consumption (K Unit)
    Figure Middle East & Africa Leukocyte Surface Antigen CD47 Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Middle East & Africa Leukocyte Surface Antigen CD47 Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Leukocyte Surface Antigen CD47 Different Application Field Consumption (K Unit)
    Figure South America Leukocyte Surface Antigen CD47 Consumption (K Unit) and Growth Rate (2015-2026)
    Figure South America Leukocyte Surface Antigen CD47 Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Leukocyte Surface Antigen CD47 Different Application Field Consumption (K Unit)
    Table US Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Canada Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Mexico Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table China Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Japan Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table India Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Korea Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Southeast Asia Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Germany Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UK Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table France Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Russia Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Italy Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Saudi Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UAE Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Egypt Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Nigeria Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table South Africa Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Brazil Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Argentina Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Colombia Leukocyte Surface Antigen CD47 Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Market Price (USD/Unit) for Each Type of Leukocyte Surface Antigen CD47 in China
    Table Market Price (USD/Unit) for Each Type of Leukocyte Surface Antigen CD47 in EU
    Table Market Price (USD/Unit) for Each Type of Leukocyte Surface Antigen CD47 in USA
    Table Market Price (USD/Unit) for Each Type of Leukocyte Surface Antigen CD47 in Japan
    Table Market Price (USD/Unit) for Each Type of Leukocyte Surface Antigen CD47 in India
    Table Market Price (USD/Unit) for Each Type of Leukocyte Surface Antigen CD47 in Southeast Asia
    Table Market Price (USD/Unit) for Each Type of Leukocyte Surface Antigen CD47 in South America
    Figure Value Chain Structure of Leukocyte Surface Antigen CD47
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Leukocyte Surface Antigen CD47
    Figure Cost Structure of Leukocyte Surface Antigen CD47 in 2020
    Table Distributors/Traders List
    Table Aurigene Discovery Technologies Profiles
    Table Aurigene Discovery Technologies Leukocyte Surface Antigen CD47 Product Introduction
    Figure Aurigene Discovery Technologies Leukocyte Surface Antigen CD47 Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Aurigene Discovery Technologies SWOT Analysis
    Table Celgene Profiles
    Table Celgene Leukocyte Surface Antigen CD47 Product Introduction
    Figure Celgene Leukocyte Surface Antigen CD47 Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Celgene SWOT Analysis
    Table Forty Seven Profiles
    Table Forty Seven Leukocyte Surface Antigen CD47 Product Introduction
    Figure Forty Seven Leukocyte Surface Antigen CD47 Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Forty Seven SWOT Analysis
    Table Surface Oncology Profiles
    Table Surface Oncology Leukocyte Surface Antigen CD47 Product Introduction
    Figure Surface Oncology Leukocyte Surface Antigen CD47 Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Surface Oncology SWOT Analysis
    Table Trillium Therapeutics Profiles
    Table Trillium Therapeutics Leukocyte Surface Antigen CD47 Product Introduction
    Figure Trillium Therapeutics Pharma & Healthcare Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Leukocyte Surface Antigen CD47 Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Leukocyte Surface Antigen CD47 Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Leukocyte Surface Antigen CD47 Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports